@article{1f2bb7638ed347dbb56849c3da61b2a0,
title = "Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: A jump with a weak parachute?",
abstract = "N/A",
keywords = "Anticoagulants, Aspirin, Atrial Fibrillation, Clinical Decision-Making, Clopidogrel, Evidence-Based Medicine, Fibrinolytic Agents, Hemorrhage, Humans, Meta-Analysis as Topic, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome, Anticoagulants, Aspirin, Atrial Fibrillation, Clinical Decision-Making, Clopidogrel, Evidence-Based Medicine, Fibrinolytic Agents, Hemorrhage, Humans, Meta-Analysis as Topic, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome",
author = "Mattia Galli and Felicita Andreotti and Gianluigi Savarese and Domenico D'Amario and Rocco Vergallo and {Della Bona}, Roberta and Leonardo Cal{\`o} and Italo Porto and Filippo Crea",
year = "2019",
doi = "10.1093/ehjcvp/pvy039",
language = "English",
volume = "5",
pages = "55--56",
journal = "EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY",
issn = "2055-6837",
publisher = "Oxford : Oxford University Press",
}